Trial Profile
Phase II Trial of Ritonavir/Lopinavir in Patients With Progressive or Recurrent High-Grade Gliomas.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Lopinavir
- Indications Glioma
- Focus Therapeutic Use
- 07 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Jul 2011 Planned end date changed from 1 Dec 2011 to 1 Jun 2010 as reported by ClinicalTrials.gov.